Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Therapeutics and Clinical Risk Management|February 20, 2010
Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malariaPauline Byakika-Kibwika, Mohammed Lamorde, Harriet Mayanja-Kizza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2009
Resurrecting the triple threat: academic social responsibility in the context of global health researchYukari C Manabe, Shevin T Jacob, David Thomas, et al.
AIDS (London, England)|May 31, 2002
Therapeutic drug monitoring in HIV infection: current status and future directionsDavid Back, Giorgio Gatti, Courtney Fletcher, et al.
AIDS (London, England)|May 2, 2012
Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatmentJ Mirjam Oudijk, Helen McIlleron, Veronica Mulenga, et al.
AIDS (London, England)|May 24, 2013
Lower artemether, dihydroartemisinin and lumefantrine concentrations during rifampicin-based tuberculosis treatmentMohammed Lamorde, Pauline Byakika-Kibwika, Jonathan Mayito, et al.
Journal of the International AIDS Society|November 14, 2014
Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implantKimberly Scarsi, Mohammed Lamorde, Kristin Darin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 7, 2012
Steady-state pharmacokinetics of lopinavir plus ritonavir when administered under different meal conditions in HIV-infected Ugandan adultsMohammed Lamorde, Pauline Byakika-Kibwika, Marta Boffito, et al.
Pageof 5